Related Experiment Videos
AIDS- and non-AIDS-related PML association with distinct p53 polymorphism
C Power1, J G Gladden, W Halliday
1Department of Clinical Neurosciences, University of Calgary, Alberta, Canada.
Abstract:
A population-based analysis of progressive multifocal leukoencephalopathy (PML) showed PML frequencies of 5.1% among patients with AIDS and 0.07% among patients with hematologic malignancies, but similar clinical features of PML in both groups. Sequencing of the p53 gene, exon 4, showed heterozygosity (Arg-Pro) at codon 72 in five of six PML patients. These findings indicate that frequencies of non-AIDS- and AIDS-related PML differ markedly but p53 polymorphisms may influence the occurrence of PML in both groups.
Insights
Progressive multifocal leukoencephalopathy (PML) is more common in AIDS patients than those with blood cancers. P53 gene variations may play a role in PML occurrence across both patient groups.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic infection of the central nervous system.
- PML is most commonly associated with severe cellular immunodeficiency, particularly in patients with acquired immunodeficiency syndrome (AIDS).
- PML can also occur in other immunocompromised states, including hematologic malignancies.
Purpose of the Study:
- To compare the frequency and clinical features of PML in patients with AIDS versus those with hematologic malignancies.
- To investigate the potential role of p53 gene polymorphisms in the occurrence of PML in these distinct patient populations.
Main Methods:
- A population-based analysis was conducted to determine PML frequencies in patients with AIDS and hematologic malignancies.
- Clinical features of PML were compared between the two groups.
- The p53 gene, specifically exon 4, was sequenced in PML patients to identify polymorphisms, particularly at codon 72.
Main Results:
- PML occurred in 5.1% of patients with AIDS and 0.07% of patients with hematologic malignancies, indicating a significant difference in frequency.
- Despite the frequency difference, the clinical presentation of PML was similar in both patient groups.
- Heterozygosity (Arg-Pro) at codon 72 of the p53 gene was observed in five out of six PML patients analyzed.
Conclusions:
- The frequency of non-AIDS-related PML (e.g., in hematologic malignancies) differs markedly from AIDS-related PML.
- p53 gene polymorphisms, specifically at codon 72, may be a contributing factor to the occurrence of PML in both AIDS and non-AIDS patients.